Your browser doesn't support javascript.
loading
Machine learning for individualized prediction of hepatocellular carcinoma development after the eradication of hepatitis C virus with antivirals.
Minami, Tatsuya; Sato, Masaya; Toyoda, Hidenori; Yasuda, Satoshi; Yamada, Tomoharu; Nakatsuka, Takuma; Enooku, Kenichiro; Nakagawa, Hayato; Fujinaga, Hidetaka; Izumiya, Masashi; Tanaka, Yasuo; Otsuka, Motoyuki; Ohki, Takamasa; Arai, Masahiro; Asaoka, Yoshinari; Tanaka, Atsushi; Yasuda, Kiyomi; Miura, Hideaki; Ogata, Itsuro; Kamoshida, Toshiro; Inoue, Kazuaki; Nakagomi, Ryo; Akamatsu, Masatoshi; Mitsui, Hiroshi; Fujie, Hajime; Ogura, Keiji; Uchino, Koji; Yoshida, Hideo; Hanajiri, Kazuyuki; Wada, Tomonori; Kurai, Kiyohiko; Maekawa, Hisato; Kondo, Yuji; Obi, Shuntaro; Teratani, Takuma; Masaki, Naohiko; Nagashima, Kayo; Ishikawa, Takashi; Kato, Naoya; Yotsuyanagi, Hiroshi; Moriya, Kyoji; Kumada, Takashi; Fujishiro, Mitsuhiro; Koike, Kazuhiko; Tateishi, Ryosuke.
Afiliação
  • Minami T; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo.
  • Sato M; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo.
  • Toyoda H; Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital.
  • Yasuda S; Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital.
  • Yamada T; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo.
  • Nakatsuka T; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo.
  • Enooku K; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo.
  • Nakagawa H; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo.
  • Fujinaga H; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo.
  • Izumiya M; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo.
  • Tanaka Y; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo.
  • Otsuka M; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo.
  • Ohki T; Department of Gastroenterology, Mitsui Memorial Hospital.
  • Arai M; Department of Gastroenterology, Toshiba General Hospital.
  • Asaoka Y; Department of Medicine, Teikyo University School of Medicine.
  • Tanaka A; Department of Medicine, Teikyo University School of Medicine.
  • Yasuda K; Department of Gastroenterology, Kiyokawa Hospital.
  • Miura H; Department of Gastroenterology, Tokyo Yamate Medical Center.
  • Ogata I; Department of Gastroenterology, Kawakita General Hospital.
  • Kamoshida T; Department of Gastroenterology, Hitachi General Hospital.
  • Inoue K; Department of Gastroenterology, Showa University Fujigaoka Hospital.
  • Nakagomi R; Department of Gastroenterology, Kanto Central Hospital of the Mutual Aid Association of Public School Teacher.
  • Akamatsu M; Department of Gastroenterology, JR Tokyo General Hospital.
  • Mitsui H; Department of Gastroenterology, Tokyo Teishin Hospital.
  • Fujie H; Department of Gastroenterology, Tokyo Shinjuku Medical Center.
  • Ogura K; Department of Gastroenterology, Tokyo Metropolitan Police Hospital.
  • Uchino K; Department of Gastroenterology, Japanese Red Cross Medical Center.
  • Yoshida H; Department of Gastroenterology, Japanese Red Cross Medical Center.
  • Hanajiri K; Department of Gastroenterology, Sanraku Hospital.
  • Wada T; Department of Gastroenterology, Sanraku Hospital.
  • Kurai K; Kurai Kiyohiko Medical Clinic.
  • Maekawa H; Department of Gastroenterology and Hepatology, Tokyo Takanawa Hospital.
  • Kondo Y; Department of Gastroenterology and Hepatology, Kyoundo Hospital.
  • Obi S; Department of Gastroenterology and Hepatology, Kyoundo Hospital.
  • Teratani T; Department of Hepato-Bililary-Pancreatic Medicine, NTT Medical Center Tokyo.
  • Masaki N; Clinical Laboratory Department, Center Hospital of the National Center for Global Health and Medicine.
  • Nagashima K; Department of Gastroenterology, National Disaster Medical Center.
  • Ishikawa T; Marunouchi Clinic.
  • Kato N; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo.
  • Yotsuyanagi H; Division of Infectious Disease and Applied Immunology, The University of Tokyo the Institute of Medical Science Research Hospital.
  • Moriya K; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo.
  • Kumada T; Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital.
  • Fujishiro M; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo.
  • Koike K; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo.
  • Tateishi R; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo. Electronic address: tateishi-tky@umin.ac.jp.
J Hepatol ; 2023 Jun 24.
Article em En | MEDLINE | ID: mdl-37716372
BACKGROUND AND AIMS: Accurate risk stratification for hepatocellular carcinoma (HCC) after achieving a sustained viral response (SVR) is necessary for optimal surveillance. We aimed to develop and validate a machine learning (ML) model to predict the risk of HCC after achieving an SVR in individual patients. METHODS: In this multicenter cohort study, 1742 patients with chronic hepatitis C who achieved an SVR were enrolled. Five ML models were developed including DeepSurv, gradient boosting survival analysis, random survival forest (RSF), survival support vector machine, and a conventional Cox proportional hazard model. Model performance was evaluated using Harrel' c-index and was externally validated in an independent cohort (977 patients). RESULTS: During the mean observation period of 5.4 years, 122 patients developed HCC (83 in the derivation cohort and 39 in the external validation cohort). The RSF model showed the best discrimination ability using seven parameters at the achievement of an SVR with a c-index of 0.839 in the external validation cohort and a high discriminative ability when the patients were categorized into three risk groups (P <0.001). Furthermore, this RSF model enabled the generation of an individualized predictive curve for HCC occurrence for each patient with an app available online. CONCLUSIONS: We developed and externally validated an RSF model with good predictive performance for the risk of HCC after an SVR. The application of this novel model is available on the website. This model could provide the data to consider an effective surveillance method. Further studies are needed to make recommendations for surveillance policies tailored to the medical situation in each country. IMPACT AND IMPLICATIONS: A novel prediction model for HCC occurrence in patients after hepatitis C virus eradication was developed using machine learning algorithms. This model, using seven commonly measured parameters, has been shown to have a good predictive ability for HCC development and could provide a personalized surveillance system.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2023 Tipo de documento: Article